EPENDYMOMA
Clinical trials for EPENDYMOMA explained in plain language.
Never miss a new study
Get alerted when new EPENDYMOMA trials appear
Sign up with your email to follow new studies for EPENDYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New proton beam technique aims to zap Kids' brain tumors with fewer side effects
Disease control Recruiting nowThis early-stage study is testing a more precise form of proton beam radiation therapy for children with a type of brain tumor called ependymoma. The main goal is to see if this refined technique is safe and causes fewer side effects by better targeting the tumor and sparing heal…
Matched conditions: EPENDYMOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for young brain cancer patients: scientists test Immune-Boosting drug combo
Disease control Recruiting nowThis study is testing whether adding a drug called ibrutinib to an existing experimental treatment can help the body's immune system fight brain cancer more effectively. It is for children and young adults (ages 6-25) whose brain cancer has come back or hasn't responded to standa…
Matched conditions: EPENDYMOMA
Phase: PHASE1 • Sponsor: Theodore S. Johnson • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists train Kids' own cells to hunt their brain cancer
Disease control Recruiting nowThis early-stage study is testing a new, personalized treatment for children with aggressive brain tumors. Doctors will take a sample of the child's tumor, grow special immune cells in a lab that are trained to attack it, and then infuse those cells back into the child's brain. T…
Matched conditions: EPENDYMOMA
Phase: PHASE1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New pill tested for Tough-to-Treat brain cancers
Disease control Recruiting nowThis is the first study in people testing an experimental pill called ONC206 for adults with recurrent brain tumors that have few treatment options. The main goal is to find the highest safe dose and understand the side effects. Researchers will enroll about 102 patients to test …
Matched conditions: EPENDYMOMA
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Custom cancer fight: doctors test tumor in a dish to pick best drugs for each child
Disease control Recruiting nowThis trial is testing a personalized approach for children and young adults whose brain tumors (medulloblastoma or ependymoma) have come back. Doctors test tumor tissue from surgery in a lab to see which FDA-approved drugs work best against it, and a team of experts creates a cus…
Matched conditions: EPENDYMOMA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Doctors test Direct-to-Brain cell therapy for Kids' devastating tumors
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for children and young adults with aggressive or returning brain tumors. Doctors collect a patient's own immune cells, engineer them in a lab to target a protein (B7H3) found on tumor cells, and then deliver these 'CAR T cells'…
Matched conditions: EPENDYMOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New hope for tough brain tumors: trial targets key cancer genes
Disease control Recruiting nowThis study is testing a new drug called PLX038 for adults with aggressive brain or spinal cord tumors that have returned or progressed. It focuses on tumors with specific genetic changes (MYC or MYCN) that drive cancer growth. The goal is to find a safe dose and see if the drug c…
Matched conditions: EPENDYMOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
New hope for kids with aggressive brain tumors: pioneering therapy delivered directly to the brain
Disease control Recruiting nowThis early-stage study is testing a new type of personalized immune therapy called B7-H3-CAR T cells for children and young adults (up to age 21) with brain tumors that have come back or haven't responded to standard treatments. The therapy involves collecting a patient's own imm…
Matched conditions: EPENDYMOMA
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
Major european study aims to crack the code on brain tumor treatment
Knowledge-focused Recruiting nowThis study is collecting information on people with various types of brain tumors to see if a new, more detailed way of classifying them helps doctors choose better treatments and predict outcomes more accurately. It will follow about 1,650 patients for up to five years to compar…
Matched conditions: EPENDYMOMA
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC